Comment
doi: 10.1111/aos.13461.
Epub 2017 Jun 21.
Efficacy of aflibercept for polypoidal choroidal vasculopathy in Caucasians
Affiliations
- PMID: 28636275
- DOI: 10.1111/aos.13461
Item in Clipboard
Comment
Efficacy of aflibercept for polypoidal choroidal vasculopathy in Caucasians
Acta Ophthalmol.
2018 Feb.
Free article
No abstract available
Comment on
-
Ethnic differences in the association of SERPING1 with age-related macular degeneration and polypoidal choroidal vasculopathy.Sci Rep. 2015 Mar 24;5:9424. doi: 10.1038/srep09424. Sci Rep. 2015. PMID: 25800435 Free PMC article.
Similar articles
-
Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):221-223. doi: 10.1007/s00417-017-3784-9. Epub 2017 Aug 21. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 28828522 No abstract available.
-
Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.Jpn J Ophthalmol. 2017 Mar;61(2):204-205. doi: 10.1007/s10384-016-0475-8. Epub 2016 Oct 5. Jpn J Ophthalmol. 2017. PMID: 27709394 No abstract available.
-
Comment on: Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience.Indian J Ophthalmol. 2018 Feb;66(2):348-349. doi: 10.4103/ijo.IJO_1034_17. Indian J Ophthalmol. 2018. PMID: 29380810 Free PMC article. No abstract available.
-
Reply to comment on: Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience.Indian J Ophthalmol. 2018 Feb;66(2):349-350. doi: 10.4103/ijo.IJO_1093_17. Indian J Ophthalmol. 2018. PMID: 29380812 Free PMC article. No abstract available.
-
Polypoidal choroidal vasculopathy and treatments.Curr Opin Ophthalmol. 2008 May;19(3):208-12. doi: 10.1097/ICU.0b013e3282fb7c33. Curr Opin Ophthalmol. 2008. PMID: 18408495 Review.
Cited by
-
Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy.BMC Ophthalmol. 2022 Jul 28;22(1):325. doi: 10.1186/s12886-022-02551-3. BMC Ophthalmol. 2022. PMID: 35902835 Free PMC article.
-
Plasma Levels of Matrix Metalloprotease MMP-9 and Tissue Inhibitor TIMP-1 in Caucasian Patients with Polypoidal Choroidal Vasculopathy.Vision (Basel). 2020 May 15;4(2):27. doi: 10.3390/vision4020027. Vision (Basel). 2020. PMID: 32429088 Free PMC article.
-
T-cell differentiation and CD56+ levels in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.Aging (Albany NY). 2017 Nov 20;9(11):2436-2452. doi: 10.18632/aging.101329. Aging (Albany NY). 2017. PMID: 29165313 Free PMC article.
-
Polypoidal choroidal vasculopathy: a comprehensive clinical update.Ther Adv Ophthalmol. 2019 Feb 27;11:2515841419831152. doi: 10.1177/2515841419831152. eCollection 2019 Jan-Dec. Ther Adv Ophthalmol. 2019. PMID: 30834360 Free PMC article. Review.
-
Anti-VEGF Treatment of Diabetic Macular Edema in Denmark: Incidence, Burden of Therapy, and Forecasting Analyses.J Pers Med. 2023 Mar 18;13(3):546. doi: 10.3390/jpm13030546. J Pers Med. 2023. PMID: 36983726 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
